Shattuck Labs opened lower at $4.99, compared with its previous close of $5.05. In the last trading session, the stock traded between $4.70 and $5.03. It showed a downward intraday trend.
An investment of $100 made 5 years ago in Shattuck Labs is now worth
$ 36.57
Resulting in a loss of
$ 63.43 (63.43%)
Note: Past profits do not guarantee future returns.
Rating from 7 Analysts
Today's Change
$-0.26 (-5.13%)
Day High
$5.03
Day Low
$4.70
Day Open
$4.99
Prev Close
$5.05
Volume
10,91,762
1W Return
-6.57%
1M Return
-21.51%
3M Return
-33.14%
6M Return
-31.75%
1Y Return
141.97%
Market Cap ($ Mn)
488
PE Ratio
-
PB Ratio
3.36
PEG Ratio
-
ROE
-64.25%
ROCE
-66.04%
EPS (TTM)
$-0.25
1 Week
-6.57%
1 Month
-21.51%
3 Months
-33.14%
6 Months
-31.75%
9 Months
17.14%
Shattuck Labs to present at September healthcare investor conferences
Shattuck Labs (NASDAQ: STTK) to present at Wells Fargo and Cantor Global Healthcare Conferences. CEO Taylor Schreiber and CFO Andrew Neill will lead fireside chats and one-on-one meetings. Wells Fargo session scheduled for September 8, 2026 at 11:00 am ET. Cantor Global session set for September 9, 2026 at 3:55 pm ET. Live webcasts available via company website with 30-day replay access.
2mo agoShattuck Labs Q2 Results: EPS misses estimate, losses widen 50% YoY
Shattuck Labs missed Q2 EPS estimates with a loss of $(0.12) per share, versus a $(0.10) consensus. This represents a 50% increase in losses compared to the prior year's $(0.24) per share, indicating continued financial headwinds despite some year-over-year movement.
3mo agoLeerink initiates coverage on Shattuck Labs with Outperform rating
Leerink Partners analyst Faisal Khurshid initiated coverage on Shattuck Labs (NASDAQ: STTK) with an Outperform rating and a price target of $16.
3mo agoShattuck Labs prices $75M public offering of common stock
Shattuck Labs, Inc. has priced a public offering of common stock and pre-funded warrants expected to generate $75 million in gross proceeds. The offering includes 10,879,376 shares of common stock at $4.00 per share and pre-funded warrants for 7,870,624 shares. The transaction is set to close on June 11, 2026, with underwriters granted a 30-day option to purchase additional shares.
5mo agoCitigroup raises Shattuck Labs price target to $18
Citigroup analyst Yigal Nochomovitz maintained a Buy rating on Shattuck Labs (NASDAQ: STTK) and raised the price target to $18 from $7.
5mo agoShattuck Labs expects ~$59.4M proceeds from exercised warrants
Shattuck Labs announced it has received notices to exercise approximately 50.6 million common stock warrants, representing 96% of those issued in its August 4, 2025 private placement. The exercise is expected to generate aggregate gross proceeds of approximately $59.4 million. Combined with existing cash reserves of approximately $90.4 million as of March 31, 2026, the company anticipates funding operations into 2029.
5mo ago| Stock | LTP | Change % | Market Cap | PE |
|---|---|---|---|---|
| $547.03 | -0.16% | $1,38,692.89M | 31.55 | |
| $61.05 | +0.38% | $1,31,510.31M | 14.39 | |
| $248.69 | -0.85% | $1,00,625.20M | - | |
| $959.41 | +4.73% | $97,505.80M | 19.64 | |
| $977.58 | +0.62% | $61,476.10M | 38.99 | |
| $419.98 | -0.95% | $46,108.31M | 65.60 | |
| $180.70 | -6.40% | $39,083.96M | - | |
| $53.87 | -0.37% | $33,618.11M | 26.24 | |
| $70.01 | +0.81% | $31,173.07M | 32.37 | |
| $41.85 | +1.60% | $30,322.88M | - | |
| $120.75 | +1.05% | $26,490.14M | - | |
| $122.27 | +1.64% | $24,922.54M | 15.85 |
An investment of $100 made 5 years ago in Shattuck Labs is now worth
$ 36.57
Resulting in a loss of
$ 63.43 (63.43%)
Note: Past profits do not guarantee future returns.
